Atrium Therapeutics
Developing precision RNA therapeutics for rare genetic cardiomyopathies.
BiotechnologyPharmaceuticals
Company facts
- Founded
- 2026
- Employees
- 47
- Headquarters
- United States
- Type
- Public
- Listed
- NASDAQ: RNA
Developing precision RNA therapeutics for rare genetic cardiomyopathies.
Company facts